SUPN
Supernus Pharmaceuticals Inc

2,375
Mkt Cap
$2.93B
Volume
15,115.00
52W High
$57.65
52W Low
$29.16
PE Ratio
-150.18
SUPN Fundamentals
Price
$50.21
Prev Close
$51.18
Open
$51.03
50D MA
$49.05
Beta
0.54
Avg. Volume
680,375.65
EPS (Annual)
$1.32
P/B
2.79
Rev/Employee
$981,924.33
$1,604.12
Loading...
Loading...
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
674

Frequently Asked Questions

What is Market Cap of Supernus Pharmaceuticals Inc?
What is the 52-week high for Supernus Pharmaceuticals Inc?
What is the 52-week low for Supernus Pharmaceuticals Inc?
What is Supernus Pharmaceuticals Inc stock price today?
What was Supernus Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Supernus Pharmaceuticals Inc?
What is the Price-to-Book ratio of Supernus Pharmaceuticals Inc?
What is the 50-day moving average of Supernus Pharmaceuticals Inc?
How many employees does Supernus Pharmaceuticals Inc have?

Latest SUPN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.